Note: Ingredients listed on restricted chemical lists
EC/CAS
263-093-9/61789-86-4
Name of the chemical
Sulfonic acids, petroleum, calcium salts
Concentration
1 - 5
General Information
Version
8.1
Revision date
2022-11-10
Product name
Z25 Fluid
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec Industrial
Manufacturer Name
ROCOL a division of ITW Ltd
Emergency telephone
+44 (0)113 232 2600, 0344 892 0111
Icons in SDS
Company Information
company name
ROCOL a division of ITW Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@rocol.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H315, H317, H319
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
: Danger
Contains
: HYDROCARBONS, C11-C14, N-ALKANES, ISOALKANES, CYCLICS, <2% AROMATICS, Sulfonic acids, (petroleum), calcium salt
Hazard statements
: H304 - May be fatal if swallowed and enters airways. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
: P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P301+P310+P331 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. Do NOT induce vomiting. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302+P352 - IF ON SKIN: Wash with plenty of water.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
